Dear all

there will be a presentation about a new type of Flow cytometer, Amnis FlowSight

by Millipore people

today at 15:00 in the seminar room of Dept of Microbiology in Kieppi building room 289B.

this information is coming in short  notice, but it would be great if you find time to attend the presentation, if the field interests you. The FS brochure (attached)  is giving good background about the instrument.

-virpi

From: martin.larsson@merckgroup.com [mailto:martin.larsson@merckgroup.com]
Sent: 18. helmikuuta 2013 21:03
To: Virpi Glumoff
Cc: sami.sivonen@merckgroup.com
Subject: Amnis FlowSight presentation this Wednesday Feb 20?

Dear Virpi.
Sami Sivonen and I are in Oulu tomorrow and Wednesday to do an instrument training and it looks as if we will finish rather early on the Wednesday (20 Feb). Last time we met you were interested in our FlowSight imaging flow cytometer and I was wondering if me and Sami could come by on Wednesday around 14-15 and present this technology? We can then either do a 1 hour seminar or meet with you to have a chat around what new material etc we have and to find out if you could benefit from the instrument. I have attached a couple of brochures and application notes below.



Best regards
Martin
________________________
Martin Larsson
Multiplex & Flow Cytometry Specialist
Merck Millipore

+46 734 477 225 (Cell)
martin.larsson@merckgroup.com

Merck Millipore is a division of Merck KGaA, Darmstadt, Germany.


This message and any attachment are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient, you must not copy this message or attachment or disclose the contents to any other person. If you have received this transmission in error, please notify the sender immediately and delete the message and any attachment from your system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not accept liability for any omissions or errors in this message which may arise as a result of E-Mail-transmission or for damages resulting from any unauthorized changes of the content of this message and any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guarantee that this message is free of viruses and does not accept liability for any damages caused by any virus transmitted therewith.

Click http://www.merckgroup.com/disclaimer to access the German, French, Spanish and Portuguese versions of this disclaimer.